A Randomized Phase II Study of Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin in the Preoperative Treatment of Locally Advanced Rectal Cancer.

Trial Profile

A Randomized Phase II Study of Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin in the Preoperative Treatment of Locally Advanced Rectal Cancer.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 13 May 2017

At a glance

  • Drugs Oxaliplatin (Primary) ; Bevacizumab; Capecitabine
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Acronyms AXE-BEAM; AXEBeam
  • Most Recent Events

    • 02 May 2017 Planned End Date changed from 1 Jul 2016 to 1 Mar 2019.
    • 20 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 05 Nov 2015 Planned End Date changed from 1 Dec 2016 to 1 Jul 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top